This suggests that loss of FBXO21 leads to decreased canonical PI3K signaling and promotes dimerization of p85α leading to cell death and differentiation of AML cells by elevated CXCL10 via ERK activation. The gene discussed is FBXO21; the disease is acute myeloid leukemia.